BHF Multidisciplinary Doctoral Training Programme (Fixed Term)

About the project

• Study at Cambridge
• About the University
• Research at Cambridge
• For Cambridge students
• For staff
• For alumni
• For our researchers
• Business and enterprise
• Colleges and Departments
• Give to Cambridge
• Libraries
• Museums and collections
• Study at Cambridge
• Undergraduate Undergraduate courses Applying Events and open days Fees and finance
• Undergraduate courses
• Applying
• Events and open days
• Fees and finance
• Postgraduate Postgraduate courses How to apply Postgraduate events Fees and funding
• Postgraduate courses
• How to apply
• Postgraduate events
• Fees and funding
• International students
• Continuing education
• Lifelong learning
• Courses in education
• About the University
• How the University and Colleges work
• Term dates and calendars
• History
• Map
• Visiting the University
• News
• Annual reports
• A global university
• Equality and diversity
• Events
• Public engagement
• Jobs
• Give to Cambridge
• Research at Cambridge
• For Cambridge students
• For staff
• For alumni
• For our researchers
• Business and enterprise
• Colleges and Departments
• Give to Cambridge
• Libraries
• Museums and collections

BHF Multidisciplinary Doctoral Training Programme (Fixed Term)

Secondary Prevention of Vascular Dysfunction and Disease

University of Cambridge, in collaboration with the University of Oxford

Start date: October 2027

Fully funded studentships

Applications are invited for the second intake of the new British Heart Foundation (BHF) 4-Year Multidisciplinary Doctoral Training Programme that brings together researchers from the Universities of Oxford and Cambridge, with a focus on Secondary Prevention of Vascular Dysfunction and Disease. This flagship programme will train the next generation of cardiovascular scientists to develop innovative, cross-disciplinary approaches to halt, stabilise and reverse vascular disease in high-risk patients.

Students will be admitted to either the University of Oxford (up to 8 studentships) or the University of Cambridge (2 studentships) and will benefit from co-supervision, training, collaboration and access to world-class research infrastructure across partner institutions.

Instructions for applying to Cambridge are given below.

Vascular diseases, including coronary artery disease, stroke and aortic aneurysm, remain leading causes of death and disability worldwide. While acute care has advanced significantly, therapeutic innovation aimed at preventing disease progression and reversing established pathology has stagnated. We will identify new targets for secondary prevention and disease regression, ultimately reducing cardiovascular risk in vulnerable populations. Recent transformative technological advances, including multi-omics and AI-enhanced imaging, provide unprecedented new opportunities to gain novel mechanistic insights and develop urgently needed treatments.

In a truly multidisciplinary programme , students will work across four interconnected research themes:

The programme leverages world-leading infrastructure including BHF Centres of Research Excellence at both institutions, large-scale clinical datasets (e.g. UK Biobank), advanced imaging platforms, spatial transcriptomics hubs, and cutting-edge immunophenotyping facilities.

This structured 4-year doctoral training programme is designed to provide a level of integration and breadth beyond that of a traditional PhD. To establish a firm foundation for doctoral research, in year 1, students will undertake core research and bespoke specialist training, as well as two 12-week laboratory rotations in complementary disciplines, before progressing to a three-year main research project. Cross-institutional symposia and cohort-building activities will feature in all four years, and there will be opportunities to interact with pharmaceutical and biotechnology partners, and to undertake training in entrepreneurship, innovation and commercial translation. The programme aims to produce graduates equipped for careers in academia, industry, biotechnology, healthcare, policy and beyond.

Each fully funded 4-year studentship includes:

-A tax-free stipend at the standard BHF rate (currently £21,747/year; rising over the 4 years)

-University tuition fees at the home rate

-Consumables budget

-Travel allowance for conferences

-Additional funds to visit partners within the programme

Studentships will fully fund those who meet the UK residency requirements (home fees). International students who are able to meet the additional costs of overseas tuition fees through other scholarships or funding schemes will also be considered.

Students must commence in October 2027.

Eligibility Applicants should hold, or expect to obtain, a first or upper second-class undergraduate degree (or equivalent) in a relevant discipline such as Biochemistry, Biomedical sciences, Bioengineering or related life science subject. We particularly encourage applications from candidates with interdisciplinary interests and from groups underrepresented in cardiovascular research.

Equality, Diversity and Inclusion We are committed to fostering an inclusive research culture aligned with the BHF "Igniting Change" strategy. Recruitment will be conducted transparently and equitably. We actively encourage applications from candidates of all backgrounds.

Application Process

Applicants should submit:

-CV

-Academic transcripts

-Covering letter/personal statement (<1000 words), outlining research interests and motivation.

-Two academic references

-Evidence of competence in English (if required)

Applications should be submitted to Cambridge via: https://www.postgraduate.study.cam.ac.uk/courses/directory/cvmdpdecr Selected applicants will be invited to interview in early January 2027. Application deadline: 8th Dec 2026

For further information Please contact: Cambridge - pgmed@medschl.cam.ac.uk

Please quote reference RC51350 on your application and in any correspondence about this vacancy.

The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.

The University has a responsibility to ensure that all employees are eligible to live and work in the UK.

• Defining disease - Deep phenotyping, imaging and patient stratification
• Elaborating mechanisms and biomarkers - Multi-omics and genetic discovery
• Modulating cell death and inflammation - Systems immunology and therapeutic targeting
• Maintaining vascular stability - Cell biology, biomechanics and regenerative approaches

Department/location

Department of Medicine

Reference

RC51350

Category

Studentships

Date published

8 October 2026

Closing date

8 December 2026

Connect with us

© 2026 University of Cambridge

• Facebook
• Instagram
• LinkedIn
• X
• YouTube
• Contact the University
• Accessibility
• Freedom of information
• Privacy policy and cookies
• Statement on Modern Slavery
• Terms and conditions
• University A-Z

Study at Cambridge

• Undergraduate
• Postgraduate
• Lifelong learning
• Courses in education

About the University

• How the University and Colleges work
• Give to Cambridge
• Jobs
• Map
• Visiting the University
• Cambridge University Press & Assessment

Research at Cambridge

• Research news
• About research at Cambridge
• Public engagement

Research areas